Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Fifth Third Bancorp
Fifth Third Bancorp cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 25.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 10,777 shares of the medical research company’s stock after selling 3,
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Shares of Charles River Laboratories International Inc. CRL rose 2.43% to $165.57 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.53% to 6,071.17 and the Dow Jones Industrial Average DJIA rising 0.38% to 44,882.13. The stock's rise snapped a two-day losing streak.
What Makes Charles River Labs (CRL) an Investment Bet?
Upslope Capital Management, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. Q4 was the most challenging quarter for upslope.
Charles River Labs to close site, lay off workers
Wilmington-based Charles River Labs is scaling back operations in North Carolina as it closes one facility and plans to wind down operations at another.
Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors
Shares of Charles River Laboratories International Inc. CRL slipped 1.13% to $164.97 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.29% to 6,101.24 and Dow Jones Industrial Average DJIA falling 0.32% to 44,424.25.
Charles River Laboratories stock hits 52-week low at $160.73
Charles River Laboratories International Inc. (CRL) stock has reached a new 52-week low, touching down at $160.73. This latest price point marks a significant downturn for the company, which has seen a -27.
Pharma researcher Charles River to close Durham facility, lay off dozens
Contract researcher Charles River Laboratories, which has been slashing costs as it faces financial headwinds, plans to ...
1,282 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Flagship Harbor Advisors LLC
Flagship Harbor Advisors LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) ...
Billion-dollar pharma company to close Triangle sites
Charles River Laboratories is closing facilities in Durham and Research Triangle Park. Charles River expects revenue to decline organically this year amid restructuring efforts. A global pharma ...
Charles River Laboratories credit outlook lowered to stable at S&P on weak 2025 guidance
The outlook for Wilmington, Massachusetts-based contract research organization (CRO) Charles River Laboratories International ...
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call ...
Morningstar3d
Charles River Laboratories International Inc CRL
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Charles River price target lowered to $195 from $210 at BofA
BofA lowered the firm’s price target on Charles River (CRL) to $195 from $210 and keeps a Neutral rating on the shares. The firm updated its ...